STYLAGE® L w/ Lidocaine

Where can I buy this product?

STYLAGE® L w/ Lidocaine is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is STYLAGE® L w/ Lidocaine?

STYLAGE® L w/ Lidocaine is a sterile, viscoelastic, injectable gel implant composed of cross-linked hyaluronic acid (HA) of non-animal origin, manufactured by Vivacy Laboratories (France). It incorporates Vivacy’s proprietary IPN-Like Technology (InterPenetrated Network) and the antioxidant Mannitol.

Designed for correcting deeper facial lines, this formulation typically contains 24mg/g of cross-linked hyaluronic acid and includes 0.3% lidocaine hydrochloride for enhanced patient comfort. STYLAGE® L is indicated for injection into the deep dermis for the treatment of deep to severe facial wrinkles and folds, such as prominent nasolabial folds and marionette lines.

Storage: Store according to manufacturer guidelines, typically between 2°C and 25°C (36°F and 77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all STYLAGE® products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners.

How does STYLAGE® L w/ Lidocaine work? (Based on Manufacturer Information)

STYLAGE® L w/ Lidocaine leverages the IPN-Like Technology to create a robust, cross-linked HA gel with properties suitable for addressing significant cutaneous depressions. This technology aims to optimize the gel’s structure for durability and good tissue integration, providing effective volume and lift for deeper wrinkles.

When injected into the deep dermis, the gel physically fills and supports the tissue, smoothing the appearance of deep to severe wrinkles like nasolabial folds and marionette lines. The inclusion of Mannitol acts as an antioxidant, potentially reducing immediate post-injection inflammation and helping to protect the HA from degradation by free radicals, which may contribute to the longevity of the results.

Treatment outcomes are intended to be immediately visible. The manufacturer typically suggests a duration of effect for STYLAGE® L lasting approximately 12 months, though individual results vary. The integrated lidocaine significantly enhances patient comfort during the procedure.

Indications for Use (Common Applications)

Based on manufacturer information and common clinical use internationally, STYLAGE® L w/ Lidocaine is typically indicated for adults seeking correction of significant facial lines:

• Correction of deep to severe nasolabial folds.
• Treatment of deep marionette lines.
• Addressing other significant facial wrinkles requiring deep dermal support.
• Potentially used for restoring volume in certain facial areas (e.g., deep cheek support – requires expert assessment).

Appropriate patient selection, correct injection depth (deep dermis), and consideration of contraindications outlined in the product IFU are essential.

Primary Benefits (Based on Manufacturer Claims)

• Formulated specifically for correcting deep to severe facial wrinkles and folds.
• Utilizes IPN-Like Technology for optimized gel properties and integration.
• Contains Mannitol antioxidant for potential enhanced durability and reduced inflammation.
• Provides immediate and noticeable correction for deep lines.
• Results claimed to last up to 12 months.
• Includes lidocaine for improved patient comfort during injection.

Side Effects and Safety Information

Practitioners must obtain and consult the complete product information provided by the manufacturer for comprehensive details on administration, contraindications, warnings, precautions, and potential adverse events before using this product. Discussing all potential risks and side effects with patients is essential. Proper deep injection technique and thorough anatomical knowledge are critical for safety.

Common side effects expected with HA filler injections include temporary, injection-site related reactions:

• Swelling
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Lumps/Bumps

Severe Adverse Events:
As with any dermal filler injection, particularly those placed in the deep dermis, there are risks of more serious complications. Practitioners must be prepared to manage adverse events. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to tissue necrosis (tissue death), scarring, or (in rare cases involving facial arteries) blindness or stroke. Prompt recognition and management protocols (including readily available hyaluronidase) are crucial.
• Severe allergic reactions or hypersensitivity to HA, lidocaine, or other components
• Inflammation, infection, or abscess formation
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation.